第99.2展示Q3 2024年度财务业绩阿波罗商业房地产金融公司。2024年10月30日，除非另有说明，资讯截至2024年9月30日。不应假设未来作出的投资将是有利可图的，或将等同于本文件中显示的投资业绩。

展望性陈述和其他披露本演示可能包含属于1933年证券法第27A条，经修订版本，以及1934年证券交易法第21E条，经修订版本含义之前瞻性陈述，并且这些陈述拟受到同等提供的安全港的保护。前瞻性陈述可能受到重大风险和不确定性的影响，其中许多难以预测，并且通常超出管理的控制范围。这些前瞻性陈述可能包括阿波罗商业房地产金融公司（“公司”，“ARI”，“我们”，“我们”和“我们的”）业务、财务状况、资金流动、营运结果、计划和目标的可能或假设未来结果的信息。在本演示中使用“相信”，“期待”，“预期”，“估计”，“计划”，“继续”，“打算”，“应该”，“可能”或类似表达的词语，拟用于识别前瞻性陈述。关于以下主题的陈述，可能为前瞻性:更高的利率和通胀;我们行业的市场趋势、房地产价值、债券市场或整体经济;ARI的业务和投资策略;ARI的营运结果;ARI能否获得并维持融资安排;预期未来资金未兑付承诺的资金提供的时间和金额;以及股本回报、投资收益率和投资房地产资产的风险，包括业务条件和整体经济的变化。前瞻性陈述基于管理对未来表现的信仰、假设和期望，考虑到ARI目前可用的所有信息。前瞻性陈述不是对未来事件的预测。这些信仰、假设和期望可能因为许多可能的事件或因素的结果而发生变化，其中并非所有事件都为ARI所知。其中一些因素在ARI年终于2023年12月31日年度报告的“风险因素”和“财务状况和营运结果的管理讨论”下有描述，以及其他提交给证券交易委员会（“SEC”）的文件中有描述，可在SEC网站www.sec.gov上查阅。如果发生变化，ARI的业务、财务状况、资金流动和营运结果可能与ARI的前瞻性陈述中表达的不同。任何前瞻性陈述仅于其作出之日期有效。随著时间的推移，出现新的风险和不确定性，管理层无法预测这些事件或它们如何可能影响ARI。除非法律要求，否则ARI无义务也无意更新或修订任何前瞻性陈述，无论是因为新信息、未来事件，还是其他原因。本演示包含根据与美国通用会计原则不同的方法计算和呈现的ARI财务结果的信息，包括可分配收入和每股可分配收入。有关“可分配收入”的定义和适用的通用会计原则财务指标与非通用会计财务指标之间的调解，请参阅第20页的定义。本演示可能包含统计数据和其他数据，这些数据有时是从或根据第三方服务提供商提供的信息编制或获得。ARI对此类信息的准确性、合理性或完整性不作明示或暗示的陈述或保证。过往表现不表明也不担保未来收益。指数绩效和收益数据仅供示意目的，并且在进行比较或用于其他目的时存在限制，该限制涉及不稳定性、信贷或其他要素（例如证券的数量和类型）。指数未受管理，不收取任何费用或开支，假设收入再投资，并且不采用特殊的投资技术，如杠杆或空头交易。这些指数均不表明ARI的任何投资未来结果。除非上下文另有要求，在本演示中对“阿波罗”的引用指的是阿波罗全球管理公司及其子公司，而在本演示中对“经理”一词指的是阿波罗全球管理公司的间接子公司ACREFI管理有限责任公司。

第三季度总结结果 ➢ 普通股股东可得净利润($95)百万美元，每股普通股稀释后为($0.69)美元 – 其中包括一笔12800万美元实现亏损，该亏损记录在一项由麻省医疗组合抵押的商业按揭贷款的拨销上(「麻萨诸塞医疗」)，使GAAP帐面价值每股受到($0.93)的影响 财务业绩 1,(a) – 可分配收益为4400万美元，每股普通股稀释后为0.31美元 ➢ 宣告每股普通股送转为0.25美元，暗示11.3%的股息率 3 ➢ 总贷款组合为78亿美元，经调整和不杠杆总回报率为8.5% – 95%头期按揭贷款 – 96%浮动利率 ➢ 平均风险评级为3.0 贷款组合 ➢ 截至目前为止承诺新贷款11亿美元(期间资金95500万美元)； 第三季度承诺59700万美元(期间资金46000万美元) (b) ➢ 截至目前为止贷款还款17亿美元，第三季度为95300万美元 4 ➢ 截至目前为止增加的资金为53100万美元，第三季度为9300万美元 (c) ➢ 结束该季度，普通股权益帐面价值为18亿美元 (d) 资本化 ➢ 我们扩大了与高盛提供的抵押信贷额度，增加24210万英镑(31460万美元美元指数) ➢ 直到2026年5月，没有企业债务到期 ➢ 2024年10月1日，7家麻萨诸塞医疗医院中的5家售予第三方，并根据我们在商业按揭贷款中的按比例利益将总交易对象分配给ARI和其他Apollo 其他后续事项的Co-Lenders。我们收到约13310万美元的对价，其中包括一张4120万美元的本票。 a) 此金额反映的是投资损失之前的可分配收益 b) 包括2024年4月出售一笔13500万美元商业按揭贷款 c) 反映每股帐面价值(不包括一般CECL准备和折旧) 为12.73美元，乘以普通股的股份外在3 d) 根据资金或承诺结束之日的汇率，所得到的美元等值 参见第21页的注脚

Per Share Overview 6 1,5,(a) Book Value per Share Distributable Earnings per Share 1,5,(a) Specific CECL Allowance Distributable Earnings per Share BVPS Post-General CECL Allowance & Depreciation ▪ ▪ Quarterly Dividend ▪ Realized Loss General CECL Allowance & Depreciation ▪ 6 Book Value per Share Roll Forward General CECL BVPS excl. General CECL BVPS Allowance & Depreciation Allowance & Depreciation December 31, 2023 $14.43 ($0.30) $14.73 1,(a) $1.01 - $1.01 (+) Diluted Distributable Earnings per share (+) Impact of share repurchases $0.12 - $0.12 (-) Common dividends declared ($0.95) - ($0.95) (-) Net increase in Specific CECL Allowance ($1.06) - ($1.06) (-) Realized loss on investments ($0.93) - ($0.93) (-) Vesting and delivery of RSUs ($0.14) - ($0.14) (-) Change in General CECL Allowance & Depreciation ($0.13) ($0.13) - (b) (-) Net loss on currency and interest hedges ($0.05) - ($0.05) 7 Change during period ($2.13) ($0.13) ($2.00) September 30, 2024 $12.30 ($0.43) $12.73 a) Amount reflects Distributable Earnings prior to net realized loss on investments and gain on extinguishment of debt 4 b) Includes net foreign currency gain, net unrealized loss on forward currency contracts and interest rate hedges, and realized gain on forward currency contracts related to principal outside impact of forward points See footnotes on page 21

Portfolio Activity & REO Overview Q3 Loan Portfolio Activity YTD Loan Portfolio Activity ($ in mm) ($ in mm) 4 4 8 7 (b) 8 7 ➢ $460 million of new loan originations, across three first mortgages REO ➢ Brooklyn Development: 51-story multifamily tower component topped out in July 2024, and interior fit-out continues to progress Highlights ➢ $953 million of loan repayments including $808 million of full repayments of six first mortgages and one subordinate loan ➢ Massachusetts Healthcare: recorded an aggregate $128 million realized loss on the REO Overview extinguishment of a commercial mortgage loan secured by eight hospitals: ($ in mm) Q3 Loan ▪ On September 4, 2024, we and Apollo Co-Lenders acquired title to one of the eight Net Net Portfolio hospitals, which was subsequently taken by eminent domain on September 27, 2024 (a) As of September 30, 2024 Assets Debt Equity Activity ▪ On September 30, 2024, the borrowers were released from their loan obligations via Brooklyn Development $495 ($206) $289 a guaranty payment and transferred the deeds of the remaining seven hospitals into D.C. Hotel 157 (73) 84 escrow Atlanta Hotel 69 - 69 ▪ The aggregate $128 million realized loss was based on the difference between the 7 Total REO Held for Investment $721 ($279) $442 loan’s amortized cost basis and the total of the eminent domain award and our allocated value of the hospitals a) Debt related to real estate owned represents construction financing on our Brooklyn Development (maximum commitment of $388 million and presented net of $2 million in deferred financing costs) and mortgage on our D.C. Hotel (maximum commitment of $74 million and presented net of $1 million in deferred financing costs) 5 b) Includes the sale of a $135 million commercial mortgage in April 2024 See footnotes on page 21

Q3’24 Loan Originations & Repayments (a) New Originations Repayments by Property Type Total Repayments Full Repayments $953 Million $808 Million/7 Loans Asset Photos Q3 repayments exceeded 1H’24 by $194 million Loan Type Floating-Rate Senior Loan Floating-Rate Senior Loan (b) Loan Size $149 million $253 million Location United Kingdom United Kingdom Six Premium Six Grade-A Collateral Senior Care Homes Logistics Developments Loan Purpose Acquisition Refinance (c) LTV 51% 61% Investment Date August 2024 August 2024 a) Excludes a loan modification accounted for as new loan under GAAP during Q3 b) Total commitment. Represents USD equivalent based on foreign exchange rates as of date funded or commitment closed c) Reflects loan-to-value (“LTV”) at the time the loan was originated 6 d) Includes Residential (1%), Office (1%) and Other (<1%) See footnotes on page 21

Loan Portfolio Overview Carrying Value/ W/A Unlevered All-in Yield 9 Loan Position 3,9,(a) Number of Loans on Loan Portfolio 95% First Mortgage $7.8 billion/45 Loans 8.5% W/A Remaining Fully-Extended 9 (b) W/A Portfolio Risk Rating W/A Portfolio Loan-to-Value 9,10 Term 3.0 58% 2.5 Years 9 (e) 9 Collateral Diversification Origination Vintage Loan Performance (c) Other $2,255 Industrial 7% Office 5% 23% $1,860 Healthcare 5% Mixed Use 5% $1,065 $975 $661 Residential $435 $413 16% Hotel 21% $98 $103 $0 $0 (d) Retail 18% 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 a) Excludes benefit of forward points on currency hedges related to loans denominated in currencies other than USD b) Weighted average loan-to-value (“LTV”) reflects the LTV at the time the loan was originated; based on amortized cost and excludes risk-rated 5 loans c) Other property types include Pubs (3%), Caravan Parks (3%) and Urban Predevelopment (1%) d) Retail property types include: Outlet Center (6%), Retail Distribution Warehouse (6%), Urban Retail (3%), and Lifestyle Center (3%) 7 e) Based on amortized cost, gross of Specific CECL Allowance. Non-performing loans represent loans placed on non-accrual status See footnotes on page 21

Loan Portfolio Overview (cont’d) ($ in mm) United New Other (b) 7 Property Type Kingdom York City Europe Southeast West Midwest Northeast Other Total Office $643 / 8% $472 / 6% $501 / 6% - - $176 / 2% - - $1,792 / 23% Hotel 7 / 0% 245 / 3% 508 / 6% 450 / 6% 208 / 3% 57 / 1% 9 / 0% 137 / 2% 1,621 / 21% Retail 945 / 12% 250 / 3% 36 / 0% 14 / 0% 77 / 1% 98 / 1% - 34 / 0% 1,454 / 18% Residential 241 / 3% 490 / 6% - 15 / 0% 225 / 3% 78 / 1% - 171 / 2% 1,220 / 16% Mixed Use 283 / 4% 151 / 2% - - - - - - 433 / 5% Industrial 128 / 2% - 290 / 4% - - - - - 418 / 5% Healthcare 355 / 5% - - - - - - - 355 / 5% (a) Other 437 / 6% - - 133 / 2% - - - - 571 / 7% 7,11 Total $3,040 / 39% $1,608 / 20% $1,335 / 17% $612 / 8% $510 / 6% $409 / 5% $9 / 0% $342 / 4% $7,865 / 100% General CECL Reserve ($34) 7 Carrying value, net $7,831 Collateral Diversification Sweden 3% United Midwest Kingdom New York 5% 39% City 20% Germany West 8% 6% Spain 3% Southeast Italy 8% 2% a) Other property types include Pubs (3%), Caravan Parks (3%) and Urban Predevelopment (1%) b) Other geographies include Southwest (2%), Mid-Atlantic (2%), and Other (1%) 8 Note: Map does not show locations where percentages are 2% or lower See footnotes on page 21

Office Loan Portfolio Overview (a) 9 (b) Number of Loans Carrying Value First Mortgage W/A Loan-to-Value 51% 10 Loans $1.8 Billion 100% rd Loans with 3 Party Largest commitment 100% 9 W/A Risk Rating (c) Subordinate Debt leased to credit tenant 2.9 3 Loans $673 million 9 9 9,10 Origination Vintage Location Fully Extended Maturities $710 $975 64% Europe $449 $461 $410 $626 $407 36% $349 $334 United States $184 $249 $223 $349 $222 $223 $0 $100 $76 $0 $112 $76 2024 2025 2026 2027 2028 2017 2018 2019 2020 2021 2022 US Originations European Originations US Maturities European Maturities a) Includes one loan secured by a portfolio which includes office, industrial, and retail property types located in various cities across Germany b) Weighted average loan-to-value (“LTV”) reflects the LTV at the time the loan was originated; based on amortized cost and excludes risk-rated 5 loans c) Portfolio includes a £308 million ($461 million in USD), based on amortized cost, first mortgage secured by an office redevelopment property in London which is 100% leased by a credit tenant for a 20-year term 9 Note: Location chart does not show locations where percentages are 2% or lower See footnotes on page 21

Senior Loan Portfolio (1 of 3) ($ in mm) Origination Amortized Unfunded Construction 3rd Party Fully-extended 10 Location Office Property Type Date Cost Commitments Loan Subordinate Debt Maturity (a) London, UK Loan 1 Office 02/2022 $461 $209 Y 02/2027 Manhattan, NY Loan 2 Office 03/2022 249 17 Y 04/2027 Long Island City, NY Loan 3 Office 01/2020 223 28 Y 03/2028 Berlin, Germany Loan 4 Office 06/2019 222 - 08/2026 London, UK Loan 5 Office 02/2020 184 5 02/2025 Milan, Italy Loan 6 Office 02/2022 165 - 06/2025 Chicago, IL Loan 7 Office 11/2022 100 - 01/2025 Chicago, IL Loan 8 Office 03/2018 76 - Y 01/2026 Subtotal - Office $1,680 $259 Hotel Various, Europe Loan 9 Hotel 12/2023 $275 - 12/2028 Various, Spain Loan 10 Hotel 10/2019 265 18 08/2027 Napa Valley, CA Loan 11 Hotel 05/2022 195 9 Y 06/2027 Loan 12 Hotel 07/2021 180 - 08/2026 Various, US St. Thomas, USVI Loan 13 Hotel 11/2021 165 - 12/2026 Manhattan, NY Loan 14 Hotel 09/2015 140 - 12/2026 St. Petersburg, FL Loan 15 Hotel 06/2024 131 - 06/2029 Loan 16 Hotel 06/2024 105 9 07/2029 Brooklyn, NY New Orleans, LA Loan 17 Hotel 10/2021 92 - 11/2026 Chicago, IL Loan 18 Hotel 05/2019 46 - 12/2025 Pittsburgh, PA Loan 19 Hotel 02/2018 27 - 11/2024 Subtotal - Hotel $1,621 $36 10 a) Loan is secured by an office redevelopment property which is 100% leased by a credit tenant for a 20-year term See footnotes on page 21

Senior Loan Portfolio (2 of 3) Origination Amortized Unfunded Construction 3rd Party Fully-extended 10 Location Retail Property Type Date Cost Commitments Loan Subordinate Debt Maturity Various, UK Loan 20 Retail 04/2022 $510 $24 04/2027 Various, UK Loan 21 Retail 10/2021 435 - 10/2026 Manhattan, NY Loan 22 Retail 08/2019 250 - Y 09/2025 Various, US Loan 23 Retail 05/2022 124 - 06/2027 (12) Cincinnati, OH Loan 24 Retail 11/2014 98 - 09/2025 Subtotal - Retail $1,417 $24 Residential Various, UK Loan 25 Residential 12/2021 $241 $12 12/2026 Various, US Loan 26 Residential 03/2023 163 - 04/2026 Emeryville, CA Loan 27 Residential 04/2024 156 - 05/2029 Loan 28 Residential 06/2024 99 - 07/2029 Washington, DC Manhattan, NY Loan 29 Residential 05/2022 94 - 06/2027 Cleveland, OH Loan 30 Residential 05/2021 76 - 05/2027 Manhattan, NY Loan 31 Residential 12/2021 15 - 01/2027 Subtotal - Residential $844 $12 Mixed Use London, UK Loan 32 Mixed Use 12/2019 $283 $1 Y 08/2025 Loan 33 Mixed Use 03/2022 151 27 03/2027 Brooklyn, NY Y Subtotal - Mixed Use $434 $28 11 See footnotes on page 21

Senior Loan Portfolio (3 of 3) Origination Amortized Unfunded Construction 3rd Party Fully-extended 10 Location Industrial Property T ype Date Cost Commitments Loan Subordinate Debt Maturity Various, Sweden Loan 34 Industrial 03/2021 $243 - 05/2026 Y Various, UK Loan 35 Industrial 08/2024 128 127 08/2029 Subtotal - Industrial $371 $127 Healthcare Various, UK Loan 36 Healthcare 07/2024 $200 - 07/2029 Various, UK Loan 37 Healthcare 08/2024 156 - 08/2029 Subtotal - Healthcare $356 - Other Various, UK Y Loan 38 Pubs 12/2023 $222 - 01/2029 (a) Various, UK Loan 39 Caravan Parks 02/2021 215 - 02/2028 Various, Germany Loan 40 Portfolio 06/2021 197 18 06/2026 Miami, FL Loan 41 Urban Predevelopment 12/2022 133 - 01/2026 Subtotal - Other $767 $18 Subtotal/W.A. - First Mortgage $7,490 $504 2.5 Years 12 a) Includes portfolio of office, industrial, and retail property types See footnotes on page 21

Subordinate Loan Portfolio ($ in mm) Origination Amortized Unfunded Construction 3rd Party Fully-extended 10 Location Property Type Date Cost Commitments Loan Subordinate Debt Maturity 13 Manhattan, NY Loan 42 Residential 06/2015 $273 - 11/2025 13 Loan 43 Residential 08/2022 74 - 11/2025 Manhattan, NY 12,13 Manhattan, NY Loan 44 Residential 05/2020 28 - 11/2025 (a),12 Troy, MI Loan 45 Office 08/2017 - - 09/2024 Total $375 - 7,9 Total/W.A. - Subordinate $375 - 1.1 Years 7,9 Total/W.A. - Portfolio $7,865 $504 2.5 Years General CECL Reserve ($34) 7 Total Carrying Value, Net $7,831 a) Loan matured in September 2024. Negotiations with sponsor currently in process. 13 See footnotes on page 21

Capital Structure Overview Capital Structure Composition Conservative Capital Management Strategy ($ in mm) No Corporate Debt ~71% Weighted Average Available (e) Maturities until May 2026 Advance Rate 14 15 (a),(b),(c) 3.5x Debt to Equity Ratio 1.3x Fixed Charge Coverage Secured Debt Arrangements $5,525 (61%) Corporate Debt Maturities Debt Related to Real Estate Owned $282 (3%) Senior Notes Term Loan Senior $500 Term $474 $1,263 Secured Loan B (14%) Notes $763 (8%) $500 (6%) Term Loan $290 $169 (2%) Preferred Stock (d) Common Equity Book Value $1,759 (20%) $0 $0 $0 2024 2025 2026 2027 2028 2029 a) Weighted-average rates of applicable benchmark rates and credit spread adjustments plus spreads of USD: +2.55% / GBP: +2.28% / EUR: +2.11% / SEK: +1.50% b) Our secured credit facilities do not contain capital markets-based mark-to-market provisions c) Consists of nine secured credit facility counterparties, one revolving credit facility and one private securitization d) Reflects book value per share (excluding General CECL Allowance and depreciation) of $12.73 multiplied by shares of common stock outstanding September 30, 2024 e) Based on maximum available advance rates across secured debt counterparties See footnotes on page 21 14

Mitigating Foreign Exchange Risk ARI is well-positioned for fluctuating foreign exchange rates due to several risk mitigating steps we have taken to structure and fund our non-US loan portfolio and associated secured financing facilities Foreign Exchange Rate Change (Local/USD) % FX Change YoY GBP: 10% EUR: 5% SEK: 7% 1.34x Mitigating Foreign Exchange Risk 1.27x 1.26x 1.26x ➢ Secured debt arrangements are structured in local currency thereby reducing FX exposure to our net equity on foreign loans. 1.22x ▪ 75% weighted average advance on total foreign loan portfolio ➢ Net equity and net interest income of foreign loans are economically hedged through forward currency contracts 1.11x 1.10x 1.08x 1.07x ▪ Forward point impact on forward currency contracts resulted in an $5.6 million realized gain in Q3 2024 1.06x Foreign Loan Capital Stack ($ in mm) Change in Unrealized Gain (Loss) on Net Equity $4,383 ($ in mm) As of September 30, 2024 Q3 2024 Net YTD 2024 Net a b (b) ( ) ( ) Currency Carrying Value Secured Debt Net Equity Unrealized Gain Unrealized Gain (Loss) Offset by local currency GBP $3,022 ($2,277) $745 $44 $35 denominated secured debt 75% $3,292 EUR $1,119 ($819) $299 $13 $5 arrangements 0.10x 0.10x 7,(c) SEK $243 ($196) $47 $2 ($1) 0.09x 0.09x 0.09x 7 Hedged with forward currency Total $4,383 ($3,292) $1,091 $59 $40 25% $1,091 contracts (c) 7,(c) Change in unrealized gain (loss) on forward contracts ($52) ($23) Net Equity Secured Debt a) Carrying value includes all commercial mortgage and subordinate loans denominated in foreign currencies with or without secured debt financing b) Represents the net change in unrealized gains (losses) on foreign loans of $231 million and respective foreign secured debt arrangements of $(172) million for the quarter ended September 30, 2024. The net change in unrealized gains (losses) on foreign loans of 15 $160 million and respective foreign secured debt arrangements of $(120) million for the nine months ended September 30, 2024 c) Represents net change in unrealized gain (loss) on forward contracts for the quarter ended September 30, 2024, excluding gains (losses) on forward currency contracts economically hedging foreign currency interest Sep-23 Dec-23 Mar-24 Jun-24 Sep-24 GBP EUR SEK

Loan Maturities and Future Funding Profile 10,16,17 Fully-Extended Loan Maturities and Expected Future Fundings by Net Equity ($ in mm) $686 $652 $632 $521 $80 $27 $33 $15 $2 $0 a 2024 2025 2026 2027 2028 & Beyond (b) (b) Fully-Extended Maturities (Net Equity) Expected Net Future Fundings 18,(c) Net Interest Income Sensitivity to Benchmark Rates +$0.01 +$0.01 +$0.01 +$0.01 $0.00 $0.00 -$0.01 -$0.01 -$0.01 -$0.02 -$0.02 Benchmark Rates Index Sep-30 -$0.04 SOFR 1M 4.85% EURIBOR 3.28% SONIA ON 4.97% -0.75% -0.50% -0.25% 0.25% Change in Benchmark Rate USD GBP EUR Note: Assumes future financing, in certain cases, against mortgages that are not currently financed. There is no assurance such future financing against mortgages that are not currently financed will occur a) Represents the period of October 1, 2024 through December 31, 2024 b) Net of expected secured credit facility advances 16 c) Reflects incremental increases in respective benchmark rates as of September 30, 2024 (SOFR 1 month: 4.85%, EURIBOR 3.28% and SONIA ON: 4.97% adjusted for compounding) See footnotes on page 21 Net Interest Income Per Share

Appendix - Consolidated Balance Sheets - Consolidated Statement of Operations - Reconciliation of GAAP Net Income to Distributable Earnings 17

Consolidated Balance Sheets ($ in thousands - except share data) September 30, 2024 December 31, 2023 Assets: Cash and cash equivalents $194,287 $225,438 (a)(c) 7,456,389 7,925,359 Commercial mortgage loans, net (b)(c) 374,222 432,734 Subordinate loans, net (d) Real estate owned, held for investment, net (net of $20,883 and $10,404 accumulated depreciation in 2024 and 2023, respectively) 708,478 519,498 Other assets 364,136 85,623 Derivative assets, net 577 29,425 Assets related to real estate owned, held for sale - 78,653 Total Assets $9,098,089 $9,296,730 Liabilities and Stockholders' Equity Liabilities: Secured debt arrangements, net $5,513,945 $5,538,476 Senior secured term loans, net 755,441 759,150 Senior secured notes, net 496,233 495,637 Debt related to real estate owned, held for investment, net 278,837 161,562 (e) Accounts payable, accrued expenses and other liabilities 165,850 120,334 Derivative liabilities, net 10,592 - Payable to related party 8,803 9,553 Liabilities related to real estate owned, held for sale - 3,285 Total Liabilities $7,229,701 $7,087,997 Stockholders’ Equity: Preferred stock, $0.01 par value, 50,000,000 shares authorized, Series B-1, 6,770,393 shares issued and outstanding ($169,260 liquidation preference) in 2024 and 2023 $68 $68 Common stock, $0.01 par value, 450,000,000 shares authorized, 138,169,164 and 141,358,605 shares issued and outstanding in 2024 and 2023, respectively 1,382 1,414 Additional paid-in-capital 2,691,776 2,727,488 Accumulated deficit (824,838) (520,237) Total Stockholders’ Equity $1,868,388 $2,208,733 Total Liabilities and Stockholders’ Equity $9,098,089 $9,296,730 a) Includes carrying value of $7,456,389 and $7,691,141 pledged as collateral under secured debt arrangements in 2024 and 2023, respectively. b) Includes carrying value of $232,817 pledged as collateral under secured debt arrangements in 2023. c) Net of $376,692 and $219,482 CECL Allowances comprised of $342,500 and $193,000 Specific CECL Allowance and $34,192 and $26,482 General CECL Allowance in 2024 and 2023, respectively. d) Includes $76,179 and $154,048 pledged as collateral under secured debt arrangements in 2024 and 2023, respectively. 18 e) Includes $3,850 and $4,017 of General CECL Allowance related to unfunded commitments on commercial mortgage loans and subordinate loans, net in 2024 and 2023, respectively. See footnotes on page 21

Consolidated Statement of Operations ($ in thousands - except share and per share data) Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Net interest income: Interest income from commercial mortgage loans $179,921 $180,441 $543,025 $520,712 Interest income from subordinate loans and other lending assets 1,210 1,599 2,901 16,416 Interest expense (134,088) (121,817) (390,447) (342,963) Net interest income $47,043 $60,223 $155,479 $194,165 Revenue from real estate owned operations 24,530 20,934 77,737 66,273 Total net revenue $71,573 $81,157 $233,216 $260,438 Operating expenses: General and administrative expenses (includes equity-based compensation of $4,165 and $12,510 in 2024 and $4,356 and $13,091 in 2023, (7,547) (7,664) (22,408) (22,150) respectively) Management fees to related party (8,801) (9,518) (27,395) (28,425) Operating expenses related to real estate owned (19,879) (18,950) (61,539) (52,917) Depreciation and amortization on real estate owned (2,342) (1,020) (9,285) (7,208) Total operating expenses ($38,569) ($37,152) ($120,627) ($110,700) Other income, net $1,573 $1,465 $2,784 $4,537 Decrease (increase) in current expected credit loss allowance, net 899 5,833 (157,043) (60,205) Foreign currency translation gain (loss) 60,102 (44,165) 39,177 (3,974) Gain (loss) on foreign currency forward contracts (includes unrealized gains (losses) of ($57,621) and ($38,657) in 2024 and $28,244 and ($27,709) in (59,535) 39,490 (29,760) 8,239 2023, respectively) Gain (loss) on interest rate hedging instruments (includes unrealized gains (losses) of ($562) and ($1,213) in 2024 and ($70) and ($9,211) in 2023, (14) (70) 436 (122) respectively) Net realized loss on investments (127,512) - (128,191) (86,604) Gain on extinguishment of debt - 30 - 495 Net income (loss) before taxes ($91,483) $46,588 ($160,008) $12,104 Income tax provision (66) (517) (280) (517) Net income (loss) ($91,549) $46,071 ($160,288) $11,587 Preferred dividends (3,068) (3,068) (9,204) (9,204) Net income (loss) available to common stockholders ($94,617) $43,003 ($169,492) $2,383 Net income (loss) per basic share of common stock ($0.69) $0.30 ($1.23) - Net income (loss) per diluted share of common stock ($0.69) $0.30 ($1.23) - Basic weighted-average shares of common stock outstanding 138,246,827 141,350,428 140,177,962 141,255,730 Diluted weighted-average shares of common stock outstanding 138,246,827 141,350,428 140,177,962 141,255,730 Dividend declared per share of common stock $0.25 $0.35 $0.95 $1.05 19 See footnotes on page 21

1 Reconciliation of GAAP Net Income to Distributable Earnings ($ in thousands - except share and per share data) Three Months Ended September 30, Nine Months Ended September 30, 1 Distributable Earnings : 2024 2023 2024 2023 ($94,617) $43,003 ($169,492) $2,383 Net income (loss) available to common stockholders: Adjustments: Equity-based compensation expense 4,165 4,356 12,510 13,091 Loss (gain) on foreign currency forwards 59,535 (39,490) 29,760 (8,239) Foreign currency loss (gain), net (60,102) 44,165 (39,177) 3,974 Unrealized loss on interest rate cap 562 70 1,213 9,211 Realized gains relating to interest income on foreign currency hedges, net 195 2,594 2,604 9,668 Realized gains relating to forward points on foreign currency hedges, net 5,587 2,784 12,823 8,461 Depreciation and amortization on real estate owned 2,342 1,020 9,285 7,208 Increase (decrease) in current expected credit loss allowance, net (899) (5,833) 157,043 60,205 Gain on extinguishment of debt - (30) - (495) Net realized loss on investments 127,512 - 128,191 86,604 Total adjustments 138,897 9,636 314,252 189,688 1,5 $44,280 $52,639 $144,760 $192,071 Distributable Earnings prior to net realized loss on investments and gain on extinguishment of debt Net realized loss on investments (127,512) - (128,191) (86,604) Gain on extinguishment of debt - 30 - 495 1 ($83,232) $52,669 $16,569 $105,962 Distributable Earnings 1 Weighted-average diluted shares – Distributable Earnings Weighted-average diluted shares – GAAP 138,246,827 141,350,428 140,177,962 141,255,730 Weighted-average unvested RSUs 2,485,258 2,832,265 2,650,308 2,966,277 1 Weighted-average diluted shares – Distributable Earnings 140,732,086 1 44,182,693 1 42,828,270 144,222,007 1,5 $0.31 $0.37 $1.01 $1.33 Diluted Distributable Earnings per share prior to net realized loss on investments and gain on extinguishment of debt 1 ($0.59) $0.37 $0.12 $0.73 Diluted Distributable Earnings per share of common stock 20 See footnotes on page 21

Footnotes 1. Distributable Earnings is a non-GAAP financial measure that we define as net income available to common stockholders, computed in accordance with GAAP, adjusted for (i) equity-based compensation expense (a portion of which may become cash-based upon final vesting and settlement of awards should the holder elect net share settlement to satisfy income tax withholding), (ii) any unrealized gains or losses or other non-cash items (including depreciation and amortization on real estate owned) included in net income available to common stockholders, (iii) unrealized income from unconsolidated joint ventures, (iv) foreign currency gains (losses), other than (a) realized gains/(losses) related to interest income, and (b) forward point gains/(losses) realized on our foreign currency hedges, (v) the non-cash amortization expense related to the reclassification of a portion of our convertible senior notes to stockholders’ equity in accordance with GAAP, and (vi) provision for loan losses and impairments. Please see page 20 for a reconciliation of GAAP net income to Distributable Earnings. 2. Reflects closing share price on October 29, 2024. 3. Weighted Average Unlevered All-in Yield on the loan portfolio is based on the applicable benchmark rates as of period end on the floating rate loans and includes accrual of origination, extension, and exit fees. For non-US deals, yield excludes incremental forward points impact from currency hedging. 4. Add-on fundings represent fundings subsequent to loan closing. 5. We believe it is useful to our investors to present Distributable Earnings prior to net realized losses on investments and gain on extinguishment of debt to reflect our operating results because (i) our operating results are primarily comprised of earning interest income on our investments net of borrowing and administrative costs, which comprise our ongoing operations and (ii) it has been a useful factor related to our dividend per share because it is one of the considerations when a dividend is determined. We believe that our investors use Distributable Earnings and Distributable Earnings prior to net realized loss on investments and gain on extinguishment of debt, or a comparable supplemental performance measure, to evaluate and compare the performance of our company and our peers. 6. Book value per share of common stock is common stockholders’ equity divided by shares of common stock outstanding. 7. Amounts and percentages may not foot due to rounding. 8. Other includes changes in General CECL Allowance, cost recovery interests, valuation allowances/reversals of valuation allowances on held for sale loans, realized loss on sale of a commercial mortgage, transfer to other assets and the accretion of loan costs and fees. 9. Based on loan amortized cost, net of Specific CECL Allowance. 10. Assumes exercise of all extension options. There is no assurance that all or any extension options will be exercised. 11. Gross of $34 million of General CECL Allowance. 12. Amortized cost for these loans is net of the recorded Specific CECL Allowances. 13. Loans are secured by the same property. 14. Represents total debt, less cash and net loan proceeds held by servicer, divided by total stockholders' equity, adjusted to add back the General CECL Allowance in line with our covenants. 15. Fixed charge coverage is EBITDA divided by interest expense and preferred stock dividends for the quarter ended September 30, 2024. 16. Future funding dates and amounts are based upon the Manager’s estimates, which are derived from the best information available to the Manager at the time. There is no assurance that the payments will occur in accordance with these estimates or at all, which could affect our operating results. 17. Excludes risk-rated 5 loans. 18. Any such hypothetical impact on interest rates on our variable rate borrowings does not consider the effect of any change in overall economic activity that could occur in a rising interest rate environment. Further, in the event of a change in interest rates of that magnitude, we may take actions to further mitigate our exposure to such a change. However, due to the uncertainty of the specific actions that would be taken and their possible effects, this analysis assumes no changes in our financial structure. There is no assurance that there will be no changes in our financial structure. The analysis incorporates movements in USD, GBP and EUR benchmark rates only. 21